Guggenheim Capital LLC Adma Biologics, Inc. Put Options Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$324 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$233 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$226 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$154 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.51B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...